Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;182(1):52-68.
doi: 10.1111/bph.17304. Epub 2024 Sep 26.

The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β-cells

Guillaume Gautheron  1 , Sylvie Péraldi-Roux  1 , Justine Vaillé  1 , Sahla Belhadj  1 , Andrzej Patyra  1   2 , Morgane Bayle  1 , Estelle Youl  1 , Soufiyan Omhmmed  1 , Mélanie Guyot  1 , Gérard Cros  1 , Jean-Francois Guichou  3 , Benjamin Uzan  4 , Jamileh Movassat  4 , Jean-François Quignard  5   6 , Jérémie Neasta  1 , Catherine Oiry  1
Affiliations

The flavonoid resokaempferol improves insulin secretion from healthy and dysfunctional pancreatic β-cells

Guillaume Gautheron et al. Br J Pharmacol. 2025 Jan.

Abstract

Background and purpose: The pharmacology of flavonoids on β-cell function is largely undefined especially in the context of defective secretion of insulin. We sought to identify flavonoids that increased the insulin-secreting function of β-cells and to explore the underlying mechanisms.

Experimental approach: INS-1 β-cells in culture and islets of Langerhans isolated from control and diabetic male rats were used for insulin secretion experiments. Pharmacological and electrophysiological approaches were used for mechanistic studies.

Key results: Among a set of flavonoids, exposure of INS-1 β-cells to resokaempferol (ResoK) enhanced glucose-stimulated insulin secretion and therefore we further characterised its activity and its pharmacological mechanism. ResoK glucose-dependently enhanced insulin secretion in INS-1 β-cells and pancreatic islets isolated from rats. Mechanistically, whole cell patch clamp recordings in INS-1 cells showed that ResoK rapidly and dose-dependently enhanced the L-type Ca2+ current whereas it was inactive towards T-type Ca2+ current. Accordingly, pharmacological inhibition of L-type Ca2+ current but not T-type Ca2+ current blocked the effects of ResoK on glucose-stimulated insulin secretion. ResoK was still active on dysfunctional β-cells as it ameliorated glucose-stimulated insulin secretion in glucotoxicity-induced dysfunctional INS-1 cells and in pancreatic islets isolated from diabetic rats.

Conclusion and implications: ResoK is a glucose-dependent activator of insulin secretion. Our results indicated that the effects of ResoK on insulin secretion involved its capacity to stimulate L-type Ca2+ currents in cultured β-cells. As ResoK was also effective on dysfunctional β-cells, our work provides a new approach to stimulating insulin secretion, using compounds based on the structure of ResoK.

Keywords: calcium channel; diabetes; insulin secretion; natural products; polyphenol.

PubMed Disclaimer

References

REFERENCES

    1. Akiyama, M., Mizokami, T., Ito, H., & Ikeda, Y. (2023). A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone. Food Science & Nutrition, 11, 5427–5437. https://doi.org/10.1002/fsn3.3499
    1. Alexander, S. P. H., Mathie, A. A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Aldrich, R. W., Attali, B., Baggetta, A. M., Becirovic, E., Biel, M., Bill, R. M., Caceres, A. I., Catterall, W. A., Conner, A. C., … Zhu, M. (2023). The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. British Journal of Pharmacology, 180(Suppl 2), S145–S222. https://doi.org/10.1111/bph.16181
    1. Anghel, S. A., Badea, R. A., Chiritoiu, G., Patriche, D. S., Alexandru, P. R., & Pena, F. (2022). Novel luciferase‐based glucagon‐like peptide 1 reporter assay reveals naturally occurring secretagogues. British Journal of Pharmacology, 179, 4738–4753. https://doi.org/10.1111/bph.15896
    1. Bailey, C. J., Flatt, P. R., & Conlon, J. M. (2023). An update on peptide‐based therapies for type 2 diabetes and obesity. Peptides, 161, 170939. https://doi.org/10.1016/j.peptides.2023.170939
    1. Bardy, G., Virsolvy, A., Quignard, J. F., Ravier, M. A., Bertrand, G., Dalle, S., Cros, G., Magous, R., Richard, S., & Oiry, C. (2013). Quercetin induces insulin secretion by direct activation of L‐type calcium channels in pancreatic beta cells. British Journal of Pharmacology, 169, 1102–1113. https://doi.org/10.1111/bph.12194

LinkOut - more resources